ReachRxResearch
Home
Research
Sign Up
Comparative efficacy and safety of treatments for eosinophilic esophagitis: Systematic review and network meta-analysis of randomized controlled trials
Back to Research Hub
  1. Home
  2. Research Hub
  3. Comparative efficacy and safety of treat…

Comparative efficacy and safety of treatments for eosinophilic esophagitis: Systematic review and network meta-analysis of randomized controlled trials

Journal of Allergy and Clinical Immunology·October 20Open Access
AllergyPractice changingEosinophilic EsophagitisSystematic Review And Network Meta-AnalysisBiologicDietary InterventionEpicutaneous ImmunotherapySwallowed Topical CorticosteroidMixedDupixentDupilumab

Summary

View source

What was studied

A systematic review and NMA of 48 RCTs (n=3,963 children and adults) compared the efficacy and safety of pharmacologic (including biologics and swallowed topical corticosteroids), dietary (food elimination diets), and mechanical interventions for eosinophilic esophagitis, searching databases to March 17, 2026.

Key findings

High-frequency dupilumab produced the greatest symptom reduction vs. placebo (MD -11.08, 95% CI -15.14 to -7.03; high certainty) and quality-of-life gain (MD +6.57, 95% CI 3.42 to 9.71; moderate certainty); swallowed topical corticosteroids were also highly effective for both outcomes (symptom MD -6.86; QoL MD +7.20; moderate certainty). Four- and six-food elimination diets showed modest symptom benefit over 1-food elimination diet (low certainty), and most interventions did not increase harms versus placebo.

Study limitations

Certainty of evidence for food elimination diets was low; histologic improvement across interventions did not reliably predict patient-important outcomes; the network relied on indirect comparisons across heterogeneous trial populations.

Clinical implications

Prioritize high-frequency dupilumab or swallowed topical corticosteroids as first-line pharmacotherapy for EoE, as both achieve meaningful symptom and quality-of-life gains with favorable safety profiles. Advise patients considering multi-food elimination diets that benefits are modest and come with significant dietary burden.

Caveats

  • Food elimination diet comparisons carry only low-certainty evidence; benefits are modest and must be weighed against the practical and psychosocial burden of dietary restriction
  • Histologic response (peak eosinophil count reduction) did not reliably translate to improvements in patient-important outcomes such as symptoms or quality of life — clinicians should not rely on histology alone to guide treatment decisions
  • Some biologic agents and epicutaneous immunotherapy showed no significant benefit over placebo for symptom outcomes (moderate certainty), suggesting class effects should not be assumed across biologics in EoE

Related Questions

Explore related topics

What is the optimal dosing frequency of dupilumab for eosinophilic esophagitis?How do swallowed topical corticosteroids compare to biologics for long-term EoE remission?What are the real-world burdens and adherence rates of food elimination diets in eosinophilic esophagitis?

Publication Details

Year
2026
Journal
Journal of Allergy and Clinical Immunology
Sample Size
n=3,963
Source
View article
Keep scrolling
More content below.
Up Next